2-溴-7-己基-9H-芴 | 99012-36-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 芴
• 中文名称: 2-溴-7-己基-9H-芴
• 英文名称: 2-Bromo-7-hexyl-9H-fluorene
• CAS: 99012-36-9
• 化学式: C₁₉H₂₁Br
• 分子量: 329.3
• InChiKey: NYQQEZMMKFKUHG-UHFFFAOYSA-N

物化性质

• 熔点：
  91-97°C

计算性质

• 辛醇/水分配系数(LogP)：
  7.2
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

安全信息

• WGK Germany：
  3

文献信息

• Polymeric Compounds And Methods Of Making And Using The Same
  申请人：Fan Xiaodong

  公开号：US20140308317A1

  公开（公告）日：2014-10-16

  The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, malaria, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; killing or inhibiting the growth of a Plasmodium species; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.

  本公开提供化合物或其药学上可接受的盐，用于抑制微生物的生长；治疗患有微生物感染，疟疾，口腔炎，眼部感染，耳部感染，癌症或结核分枝杆菌感染的哺乳动物；杀死或抑制疟原虫的生长；抑制结核分枝杆菌的生长；调节哺乳动物的免疫反应；或拮抗非分散肝素，低分子量肝素或肝素/低分子量肝素衍生物。
• Organic semiconductor material
  申请人：Tokyo Institute of Technology

  公开号：US10937964B2

  公开（公告）日：2021-03-02

  The purpose of the present invention is to provide an organic semiconductor material having liquid crystallinity and high electron mobility. The present invention is an organic semiconductor material having at least a charge-transporting molecular unit (A) having a structure of an aromatic fused ring system and a cyclic structural unit (B) bonded to the aforementioned unit via a single bond, wherein the unit (A) and/or the unit (B) has a side chain composed of a unit (C), and wherein the organic semiconductor material exhibits a liquid crystal phase that is different from an N-phase, an SmA-phase or an SmC-phase.

  本发明的目的是提供一种具有液态结晶性和高电子迁移率的有机半导体材料。本发明是一种有机半导体材料，至少具有一个具有芳香族熔环系统结构的电荷传输分子单元（A）和一个通过单键与上述单元结合的环状结构单元（B），其中单元（A）和/或单元（B）具有由单元（C）组成的侧链，并且该有机半导体材料呈现出不同于N相、SmA相或SmC相的液晶相。
• ORGANIC SEMICONDUCTOR MATERIAL
  申请人：Tokyo Institute of Technology

  公开号：EP3428987B1

  公开（公告）日：2020-02-26
• Non-crystallizable Pi-conjugated Molecular Glass Mixtures, Charge Transporting Molecular Glass Mixtures, Luminescent Molecular Glass Mixtures, or Combinations Thereof for Organic Light Emitting Diodes and other Organic Electronics and Photonics Applications
  申请人：Molaire Consulting

  公开号：US20150275076A1

  公开（公告）日：2015-10-01

  The present invention provides charge transporting molecular glass mixtures, luminescent molecular glass mixtures, or combinations thereof comprising at least two nonpolymeric compounds each independently corresponding to the structure (R 1 Y 1 ) p [(Z 1 Y 2 ) m R 2 Y 3 ] n Z 2 Y 4 R 3 wherein m is zero or one; n is zero up to an integer at which said compound starts to become a polymer; p is an integer of from one to eight; each R 1 and R 3 is independently a monovalent aliphatic or cycloaliphatic hydrocarbon group having 1 to 20 carbon atoms, an aromatic group or a multicyclic aromatic nucleus; R 2 , Z 1 , and Z 2 each independently represent multivalent aliphatic or cycloaliphatic hydrocarbon groups having 1 to 20 carbon atoms or an aromatic group; and Y 1 , Y 2 , Y 3 and Y 4 each independently represent a triple bond, a double bond, or a single bond link.
• [EN] POLYCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉS POLYCYCLIQUES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
  申请人：CELLCEUTIX CORP

  公开号：WO2014093225A2

  公开（公告）日：2014-06-19

  The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, malaria, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; killing or inhibiting the growth of a Plasmodium species; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.